Eko Analysis Software vs AVIEW
AI Verdict
Choose Eko Analysis Software if…
Choose Eko Analysis Software if your primary need is real-time, AI-assisted auscultation for early detection of heart murmurs and atrial fibrillation at the point of care or during telehealth consultations. This tool is ideal for clinicians seeking to quickly screen patients for common cardiovascular conditions using a digital stethoscope, with the ability to record, visualize, and securely store heart sounds and ECGs.
View Eko Analysis Software →Choose AVIEW if…
Choose AVIEW if your practice requires advanced AI-driven analysis of CT scans for comprehensive detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification. This platform is best suited for radiologists and specialists who need detailed quantitative assessments, automated segmentation, and workflow integration to enhance diagnostic precision and manage patient follow-ups efficiently across multiple pulmonary and cardiac conditions.
View AVIEW →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Analysis Software | AVIEW |
|---|---|---|
| Pricing | Unknown | Subscription; one-off payment |
| Deployment | Unknown | Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker) |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Analysis SoftwareEko Analysis Software integrates with digital stethoscopes and a mobile app, offering a freemium model that suggests a focus on ease of adoption and direct clinician use. The mobile-first approach and basic free features likely contribute to a more intuitive and accessible user experience for individual practitioners. AVIEW, designed for radiologists analyzing complex CT scans, implies a more specialized and potentially steeper learning curve.
Clinical Value
AVIEWWhile both tools offer significant, FDA-cleared clinical value in their respective specialties, AVIEW provides comprehensive multi-disease analysis from a single CT scan for lung cancer, COPD, and coronary artery calcification, including ILD pattern analysis. This breadth and depth of diagnostic insight from one imaging modality offer a broader clinical impact compared to Eko's point-of-care cardiovascular screening.
Pricing & Value
Eko Analysis SoftwareEko Analysis Software's freemium model allows basic app features for free, with a subscription required for full AI-powered detection and advanced functionalities. This offers a low barrier to entry and allows users to experience core benefits before committing to a paid plan. AVIEW's subscription or one-off payment model, based on installations and users, is typical for enterprise software but lacks the initial accessibility of a freemium offering.
Enterprise Readiness
AVIEWAVIEW offers extensive deployment flexibility, including cloud, hybrid, on-premise, and virtualized solutions, along with explicit features for workflow automation and integration with PACS/RIS/CIS. This robust integration capability and diverse deployment options make it highly adaptable for large-scale hospital and imaging center environments, surpassing Eko's cloud-based, mobile-centric approach for enterprise-level IT infrastructure.
Innovation
AVIEWAVIEW's comprehensive AI platform for multi-disease analysis (lung cancer, COPD, CAC, ILD) from a single CT scan, coupled with automated segmentation and 3D visualizations, represents a higher degree of innovation in complex diagnostic imaging. Eko innovates by bringing AI to point-of-care auscultation, but AVIEW's multi-faceted approach to complex imaging data stands out for its diagnostic depth and efficiency.
Support & Docs
Eko Analysis SoftwareEko Analysis Software offers a more robust and publicly accessible suite of support and documentation, including detailed user manuals, quick start guides, a comprehensive online help center with FAQs, troubleshooting tips, video tutorials, and direct contact channels. While AVIEW mentions a customer service team, Eko provides more extensive self-help and educational resources for its user base.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Analysis Software | AVIEW |
|---|---|---|
| Name | Eko Analysis Software | AVIEW |
| Company | Eko Devices | Coreline Soft Co. |
| Primary Clinical Focus | Cardiovascular diseases (heart murmurs, atrial fibrillation) | Lung cancer, COPD, and coronary artery calcification from CT scans |
| Key Features (Examples) | FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, Recording, playback, and annotation of heart sounds and ECGs | AI-powered lung nodule detection and characterization, Emphysema quantification and low attenuation area (LAA) analysis, Coronary artery calcium (CAC) scoring |
Videos
Demos, reviews, and walkthroughs featuring Eko Analysis Software and AVIEW.